<div id="readability-page-1"><div>Russell Alan J Officer and Director of Edgewise Therapeutics Inc [EWTX] filed a Form 4 on November 13, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>11/12/25</td><td>Exercise(1)</td><td>100,000</td><td>$0.18</td><td>$18,000</td></tr><tr><td>11/12/25</td><td>Sale</td><td>100,000</td><td>$21.12</td><td>$2,112,450</td></tr></tbody></table></div>Ending Holdings: 23,400 - Direct<ul><li>(1)</li><li>Exercised 4.4 years after vest date and 6.6 years before expiration date.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

EWTX

Russell Alan J, Officer and Director of Edgewise Therapeutics Inc [EWTX], filed a Form 4 on November 13, 2025, disclosing the sale of 100,000 shares at $21.12 each, totaling $2.1 million. Post-transaction, his direct holdings are 23,400 shares.

Officer/Dir Russell Sells 100,000 ($2.1M) Of Edgewise Therapeutics Inc [EWTX]